Skip to Content

Dipyridamole use while Breastfeeding

Drugs containing Dipyridamole: Aggrenox, Persantine, Persantine IV

Medically reviewed by Drugs.com. Last updated on Jan 28, 2021.

Dipyridamole Levels and Effects while Breastfeeding

Summary of Use during Lactation

No published information is available on the use of dipyridamole during breastfeeding, although labeling states that the drug is excreted into human milk. Until more data become available, dipyridamole should be used with caution during breastfeeding, especially while nursing a newborn or preterm infant. If it is used by a nursing mother, monitor the infant for bruising and bleeding.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Aspirin

Substance Identification

Substance Name

Dipyridamole

CAS Registry Number

58-32-8

Drug Class

  • Breastfeeding
  • Lactation
  • Phosphodiesterase Inhibitors
  • Vasodilator Agents
  • Platelet Aggregation Inhibitors

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.